Effects of p90 ribosomal S6 kinase pathway in breast cancer and its mechanism
10.3760/cma.j.issn.1673-422X.2011.06.014
- VernacularTitle:p90核糖体S6激酶通路在乳腺癌中的作用及其机制
- Author:
Xia BING
;
Wang GANG
- Publication Type:Journal Article
- Keywords:
Ribosomal protein S6 kinases,90-kDa;
Breast neoplasms;
Cell proliferation;
Survival:Neovascularization,pathologic
- From:
Journal of International Oncology
2011;38(6):441-444
- CountryChina
- Language:Chinese
-
Abstract:
p9O ribosomal S6 kinases(BSKs)are overexpressed in 50% human breast cancer. RSKs enhance the proliferation of breast cancer cells by regulating several key breast cancer-related proteins. They also improve survival of the breast cancer cells through regulating translocation and translation of mRNA. In addition. RSK promotes tumor angiogenesis by interaction with estrogen receptor. However, RSK4 may play an inhibitory role in breast cancer. In general, except RSK4,RSKs may become promising targets of breast cancer therapy.